The current strategy used in Europe to mitigate malaria transfusion risk is efficient with just 10 reported cases over the past 20 years, but current serological tests used to identify “at risk” donors are not sensitive enough to completely eliminate the risk.
Scientists show how the latest CRISPR-Cas gene editing technology can be used to help modify and attack AMR bacteria.
Experts are looking to use the Nobel winning technology to target resistance genes and make bacteria sensitive to first line antibiotics again; but the bacteria have ways to fight back.
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial.
An African infectious disease expert discusses how effective public health communication is critical for fighting epidemics and saving lives across the African continent.
Experts are looking to use the Nobel winning technology to target resistance genes and make bacteria sensitive to first line antibiotics again; but the bacteria have ways to fight back.
An analysis of more than 1,300 German adults hospitalised with moderate COVID-19 finds treatment with antibiotics was associated with five times greater likelihood of COVID-19 deterioration compared to patients not given antibiotics.
The Microbiologist has been shortlisted for the MEMCOM award for Best Magazine Launch or Re-launch. Subscribe now to make sure you don't miss out on the latest news, features, careers and opinion.
SubscribeA groundbreaking collaboration will combat global health challenges in tuberculosis through innovative technology.
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
Scientists show how the latest CRISPR-Cas gene editing technology can be used to help modify and attack AMR bacteria.
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial.
A synthetic droplet may give researchers clues on how the simplest forms of life on the planet could navigate their surroundings.
An African infectious disease expert discusses how effective public health communication is critical for fighting epidemics and saving lives across the African continent.
Clinical and public health microbiologists have called for investment in technology, capacity, expertise, and collaboration to put genomic surveillance of pathogens at the forefront of future pandemic preparedness.
A novel approach to drug discovery is enabling University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and commercial investment.